How Immuneering Corporation stacks up

IMRX · against 588 other Healthcare companies listed in US-listed

Valuation

8/ 100

Near the bottom of its peers.

Ranked #313 of 589 · scores higher than 3% of peers

Bars: peers in each 10-point band of the valuation score

277 peers with a valuation score of 0–9, including IMRX · Click a bar to see the companies

Why valuation scores 8?

Weighted metrics compared with all Healthcare companies.

Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.

Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -68.7% vs peer median 4.0%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -24.1% vs peer median 1.5%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -23.9% vs peer median 0.0%

Metric by metric

Position: dot = IMRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	IMRX	Peer median	Better than	Weight
Earnings yieldHigher is better · 577 reported	-25.3%	-4.3%	18%	30%
EBITDA yieldHigher is better · 578 reported	-68.7%	-0.8%	7%	50%
Free cash flow yieldHigher is better · 553 reported	-23.9%	-2.3%	13%	20%
Book yieldHigher is better · 587 reported	80.1%	25.9%	87%	Context only

Ranking by valuation score

Top 5 and the companies ranked around IMRX

Rank	Company	Market cap	Valuation	Overall
1	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	98	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	96	97
2	CorMedix Inc.CRMD · US-listed	433M USD	96	81
2	Community Health Systems, Inc.CYH · US-listed	289M USD	96	57
2	InMode Ltd.INMD · US-listed	810M USD	96	69
⋯
313	Inhibikase Therapeutics, Inc.IKT · US-listed	207M USD	8	41
313	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	8	27
313	Immix Biopharma, Inc.IMMX · US-listed	552M USD	8	39
313	Immunome, Inc.IMNM · US-listed	2.4B USD	8	27
313	Immuneering CorporationIMRX · US-listed	238M USD	8	41
313	Immatics N.V.IMTX · US-listed	1.1B USD	8	26
313	Immunovant, Inc.IMVT · US-listed	6.0B USD	8
313	Inhibrx Biosciences, Inc.INBX · US-listed	1.2B USD	8	6
313	Inovio Pharmaceuticals, Inc.INO · US-listed	172M USD	8	3

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…